The regeneration of damaged connective tissue: wishful thinking or reality?

This review provides a clinical and biological analysis/overview of publications that have identified injectable therapeutics including mesenchymal stem cells (MSCs), platelet-rich plasma (PrP) and Gold-induced cytokines (GOLDIC), in the regeneration and repair of tissue based on various clinical use, in vitro studies and with evidence provided by MRI or other imaging techniques. The review describes the advantages of micro-fragmented adipose tissue and its medicinal properties created through release of blood vessel-derived pericytes or MSCs and the work goes on to specify some of the critical growth factors and cytokines involved in tissue regeneration and repair including fibroblast growth factor, platelet derived growth factor, transforming growth factor-β, vascular endothelial growth factor and various cytokines. Evidence is provided on the mechanism through which adipose-derived MSCs can re-establish an optimal tissue micro-environment through paracrine signalling mechanisms allowing a natural promotion of healing and regeneration. There is some promising early evidence that gold-activated plasma may also benefit and enhance recovery through increased anti-inflammatory activities through production of gelsolin-although this is not clinically proven to date.​


Read the full study here

Get in touch

Find your clinic

We offer appointments nationwide and now working with partners abroad providing cutting edge Regenerative Medicine to patients in Dubai, Australia, Spain and Pakistan.

Sign-up to receive our recent news and the latest developments in regenerative medicine.

You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at info@theregenerativeclinic.co.uk. We will treat your information with respect. For more information about our privacy practices please visit our website. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.